the world's first FDA Cleared cellular-enabled Blood Glucose Meter!

 

Global total health, LLC has aligned itself with the world's first FDA Cleared cellular-enabled Blood Glucose Meter.

Global Total Health, LLC is an exclusive marketer for Telcare, Inc.

 

The Telcare BGM® automatically uploads readings to your online portal and to the family members and healthcare providers of your choice

 

Adherence to diabetes testing and glucose control saves lives, prevents complications, and saves insurers thousands of dollars per person per year. Incorporating the Telcare glucose meter and data platform into your disease management programs can help you improve their effectiveness and reduce the cost of diabetes management. Telcare’s executives have held senior roles in the country’s largest insurers and diabetes supply companies. We are committed to helping minimize the impact diabetes has on your insured population.

 

Telcare uses award-winning cellular machine-2-machine technology to bridge the last mile between patients and their caregivers in order to improve the care of chronic illness. Telcare’s first product is the Telcare BGM, a cellular-enabled blood glucose meter for the 28 million Americans and 100 million addressable patients worldwide who have diabetes that instantly transmits glucose values to a care-management server and provides instant feedback and coaching to patients with diabetes. In addition to directly reducing cost of care by improving outcomes and preventing complications, Telcare creates an ecosystem of care that provides caregivers and disease managers with previously-unavailable actionable clinical data. There is no charge for the Telserve health professional portal.

 

Telcare’s Market: Worldwide, there are more that 100 million addressable patients with diabetes, 28 million of whom are in the U.S. Current global sales for diabetes testing solutions exceed $12 billion. All U.S. health insurers, both public and private, and all EU, Canadian, and GCC health insurers reimburse for diabetes testing. Telcare’s business model is to replace legacy, unconnected solutions within the current reimbursement guidelines and at the current price points. Insurers have an overwhelming incentive to improve the quality of and compliance with diabetes testing, since the data overwhelmingly show a huge reduction in costs (around $4000/yr in the US) associated with compliance in patients with diabetes.

 

The Challenge of Diabetes: Compliance with care is well known to reduce the incidence of diabetes complications, most notably stroke, heart attack, retinal hemorrhage, and amputation. Even a 10% improvement in glucose control reduces incidence of complications by 37%. Today, patients are seen episodically by caregivers and expected to comply with complicated regimens of testing and treatment. Telcare’s solution constantly monitors the patient’s compliance and provides ongoing caregiver coaching and feedback at the moment of care, when it is most likely to be effective.

 

Telcare’s Solution: The Telcare BGM is the world’s first cellular-enabled glucose meter, with embedded cellular technology. This FDA-regulated class II medical device is paired with Telcare’s back-end clinical server and a suite of smartphone apps in order to provide a complete ecosystem of care. The server connects directly to electronic medical record systems, while the phone apps are used by parents of children with diabetes and those caring for elderly people with diabetes. The solution is FDA- and HIPAA- compliant.

 

Awards and Recognition: Telcare has been awarded two First Place E-Tech awards by CTIA, been named the MEDTEC startup of the year, been awarded the Triple Tree Award at the Wireless Life Sciences Alliance and been awarded the 2012 Edison Gold Award. Telcare’s products have been featured in the Wall Street Journal, the New York Times, Forbes, Fox News, and numerous other media sources.